However, our findings of decreased grey matter volumes in regions with high tau-PET signal are suggestive of an underlying pathological process, and since these patients are AD biomarker negative and have no clinical or imaging features of other tauopathies, one needs to consider CTE a possibility. Here, MAPT is linked to Alzheimer disease.